|
Volumn 3, Issue 2, 1996, Pages 83-88
|
Prodrug-activated gene therapy: Involvement of an immunological component in the "bystander effect"
|
Author keywords
Bystander effect; Immunological component; Prodrug activated gene therapy
|
Indexed keywords
GANCICLOVIR;
PRODRUG;
THYMIDINE KINASE;
ADENOCARCINOMA;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
CD4 CD8 RATIO;
CELL CULTURE;
COLON TUMOR;
DOWN REGULATION;
DRUG EFFECT;
FEMALE;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HERPES SIMPLEX VIRUS;
IMMUNOHISTOCHEMISTRY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOLOGY;
METHODOLOGY;
MOUSE;
NONPARAMETRIC TEST;
NUDE MOUSE;
PATHOLOGY;
PHENOTYPE;
TUMOR ASSOCIATED LEUKOCYTE;
ADENOCARCINOMA;
ANIMALS;
CD4-CD8 RATIO;
COLONIC NEOPLASMS;
DOWN-REGULATION;
FEMALE;
GANCICLOVIR;
GENE THERAPY;
GENETIC VECTORS;
IMMUNE TOLERANCE;
IMMUNOHISTOCHEMISTRY;
LYMPHOCYTES, TUMOR-INFILTRATING;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
PHENOTYPE;
PRODRUGS;
SIMPLEXVIRUS;
STATISTICS, NONPARAMETRIC;
THYMIDINE KINASE;
TUMOR CELLS, CULTURED;
|
EID: 0030100158
PISSN: 09291903
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (147)
|
References (3)
|